Aspirin; Pravastatin Sodium Patent Expiration
Aspirin; Pravastatin Sodium is Used for secondary prevention of coronary events in men and women with normal cholesterol levels who have had a myocardial infarction. It was first introduced by Bristol Myers Squibb Co
Aspirin; Pravastatin Sodium Patents
Given below is the list of patents protecting Aspirin; Pravastatin Sodium, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Pravigard Pac (copackaged) |
US5622985 (Pediatric) | Method for preventing a second heart attack employing an HMG CoA reductase inhibitor |
Oct 22, 2014
(Expired) | Bristol Myers Squibb |
Pravigard Pac (copackaged) | US5622985 | Method for preventing a second heart attack employing an HMG CoA reductase inhibitor |
Apr 22, 2014
(Expired) | Bristol Myers Squibb |
Aspirin; Pravastatin Sodium's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List